MIMEDX Group, Inc.

Home
United States
Atlanta, GA
MIMEDX Group, Inc.

Patients are why we are here. MIMEDX has supplied over two million allografts, through both direct and consignment shipments.

MIMEDX is an industry leader in utilizing amniotic tissue as a platform for regenerative medicine, developing and distributing placental tissue allografts with patent-protected, proprietary processes for multiple sectors of healthcare. As a pioneer in placental biologics, we have both a core business, focused on addressing the needs of patients with acute and chronic non-healing wounds, and a prom

ising late-stage pipeline targeted at decreasing pain and improving function for patients with degenerative musculoskeletal conditions. We derive our products from human placental tissues and process these tissues using our proprietary methods, including the PURION® process. We employ Current Good Tissue Practices, Current Good Manufacturing Practices, and terminal sterilization to produce our allografts. For additional information, please visit www.mimedx.com.

03/17/2026

For 15 years, EPIFIX® and AMNIOFIX® have helped shape the use of placental allografts in wound care and surgical applications.

At SAWC Spring 2026, we’re celebrating that milestone while looking ahead to what’s next. Visit the MIMEDX team at booth 809 to explore how our growing portfolio continues to evolve to meet the needs of clinicians managing complex wounds and surgical sites.

03/16/2026

Medicare policy is evolving—and understanding coverage expectations and prior authorization requirements for CTPs is more important than ever.

In this Just The Facts on-demand webinar, reimbursement expert Kathleen D. Schaum breaks down what wound care programs should know about 2026 Medicare coverage and WISeR prior authorization.

▶️ Watch the webinar on demand: https://mimedx.info/Just-The-Facts-WISeR-On-Demand

03/12/2026

For over 15 years, AMNIOFIX® has supported surgeons across multiple specialties by offering a protective barrier on acute and chronic wounds and exposed tissues to support the healing cascade.

Its continued use reflects the importance of AMNIOFIX as a trusted product that is informed by clinical experience and evolving surgical needs.

Explore how AMNIOFIX is used across surgical specialties: https://bit.ly/3vY9og9

03/11/2026

Today’s wound care landscape is more complex than ever — and clinicians need more than product innovation. They need context, evidence, and clarity.

At SAWC Spring 2026, MIMEDX is hosting a focused discussion designed to support clinical decision-making through a deeper understanding of biologic science and real-world data. We look forward to meaningful conversations with providers who are committed to advancing care.

📅 April 9, 2026
⏰ 12:15–1:45 PM
📍 Charlotte Convention Center

Add this session to your agenda here: https://mimedx.info/SAWC-Spring-26-Agenda

03/05/2026

Facing a challenging series of surgical procedures related to a perforated colon and subsequent complications, Kirt was looking for a better outcome.

Listen to his journey and check out the full version on our website: https://mimedx.info/Patients-Caregivers

03/03/2026

The Clinical Documentation Improvement Program from WoundGenex helps clinicians strengthen administrative confidence while maintaining focus on patient outcomes.

🔗Watch the overview video to learn more about our partnership with WoundGenex: https://mimedx.info/woundgenex

02/26/2026

With recent Medicare policy changes, reimbursement for wasted product is no longer guaranteed. For wound care clinicians, this means every square centimeter counts.

MIMEDX offers a wide range of size-appropriate allografts to help minimize waste, create an environment that supports healing, and maintain compliance.

Discover how precision sizing can make a difference for your patients and your practice: https://mimedx.info/Contact-Us

02/04/2026

Precision matters in PRP preparation. RegenKit®-Wound Gel is a fully autologous PRP solution engineered to remove iron-laden red blood cells while concentrating key biological components within a natural fibrin scaffold.

It can be applied topically in two forms – as a wound gel or with a spray applicator. Contact us to get started: https://mimedx.info/Contact-Us

01/29/2026

Just the facts on the 2026 MPFS Final Rule. Join us for JUST THE FACTS, an on-demand WEBINAR with Kathleen Schaum, for practical guidance on preparing for the year ahead.

Prepare with facts. Register today: https://mimedx.info/Just-The-Facts-PFS-On-Demand

01/28/2026

Wound care is evolving, and so are the policies that govern it. With Medicare no longer covering wasted product, efficiency is essential. MIMEDX offers solutions that fit. Our size-specific allografts help clinicians deliver optimal care while reducing unnecessary costs.

See how we’re helping you redefine wound care: https://mimedx.info/Contact-Us

01/27/2026

Wondering how the new MPFS impacts your wound care practice? Kathleen Schaum explains what matters most. This episode of JUST THE FACTS delivers a fact-based look at coding, payment, and compliance considerations for skin substitutes.

Just the facts, now on demand. Register now: https://mimedx.info/Just-The-Facts-PFS-On-Demand

01/22/2026

Policy updates are reshaping wound care reimbursement. Oversized grafts can lead to unnecessary waste—and lost revenue.

MIMEDX provides a full portfolio of size-specific allografts, helping clinicians deliver efficient, cost-conscious care without compromising outcomes.

Learn why choosing the right size matters more than ever: https://mimedx.info/Contact-Us

Address

Atlanta, GA

Telephone

+17706519100

Website

http://www.mimedx.com/

Alerts

Be the first to know and let us send you an email when MIMEDX Group, Inc. posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Shortcuts

Want your practice to be the top-listed Clinic in Atlanta?